Katharina Batzke
Overview
Explore the profile of Katharina Batzke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boedecker-Lips S, Batzke K, Klimpke P, Holtz S, Kraus D, Weinmann-Menke J
Blood Purif
. 2023 Jun;
52 Suppl 1:95-97.
PMID: 37331351
Background: The Toray Filtryzer™-NF is a new polymethyl methacrylate filter with improved hemocompatibility and reduced impact on platelet counts. Objectives: This suggests that, if necessary, a reduction in anticoagulation may...
2.
Mark M, Wollenweber P, Gesk A, Kosters K, Batzke K, Janoschka C, et al.
Commun Biol
. 2019 Oct;
2:373.
PMID: 31633064
Aggressive behavior in our modern, civilized society is often counterproductive and destructive. Identifying specific proteins involved in the disease can serve as therapeutic targets for treating aggression. Here, we found...
3.
Batzke K, Buchel G, Hansen W, Schramm A
Int J Mol Sci
. 2018 Mar;
19(3).
PMID: 29498681
Galectin-1 (Gal-1) has been described to promote tumour growth by inducing angiogenesis and to contribute to the tumour immune escape. We had previously identified up-regulation of Gal-1 in preclinical models...
4.
Pajtler K, Sadowski N, Ackermann S, Althoff K, Schonbeck K, Batzke K, et al.
Oncotarget
. 2016 Dec;
8(4):6730-6741.
PMID: 28036269
Polo-like kinase 1 (PLK1) is a serine/threonine kinase that promotes G2/M-phase transition, is expressed in elevated levels in high-risk neuroblastomas and correlates with unfavorable patient outcome. Recently, we and others...
5.
Buchel G, Schulte J, Harrison L, Batzke K, Schuller U, Hansen W, et al.
Oncoimmunology
. 2016 Jul;
5(5):e1131378.
PMID: 27467948
Galectin-1 (Gal-1) has been described to promote tumor growth by inducing angiogenesis and to contribute to tumor immune escape by promoting apoptosis of activated T cells. We had previously identified...